Fredun Pharma, a company in the Pharmaceuticals industry, reported revenue of ₹268 crore and net profit of ₹19 crore for the September 2026 quarter.
Fredun Pharma (NSE: FREDUN) closed at ₹1,693.90 on 20 Nov 2026. Its market capitalisation is ₹2,901 crore and it trades at 54.2 times earnings.
Incorporated in 1987, Fredun Pharmaceuticals Ltd manufactures & exports healthcare and pharmaceuticals products
Descriptive research only, not investment advice. Evenstocks is not a SEBI-registered investment adviser.